<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>market access on Degang Wang</title>
    <link>https://wangdegang.github.io/tags/market-access/</link>
    <description>Recent content in market access on Degang Wang</description>
    <image>
      <title>Degang Wang</title>
      <url>https://wangdegang.github.io/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E</url>
      <link>https://wangdegang.github.io/%3Clink%20or%20path%20of%20image%20for%20opengraph,%20twitter-cards%3E</link>
    </image>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <lastBuildDate>Sat, 22 Jul 2023 19:34:05 -0400</lastBuildDate><atom:link href="https://wangdegang.github.io/tags/market-access/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Market Access</title>
      <link>https://wangdegang.github.io/posts/2023-07-22-ma/</link>
      <pubDate>Sat, 22 Jul 2023 19:34:05 -0400</pubDate>
      
      <guid>https://wangdegang.github.io/posts/2023-07-22-ma/</guid>
      <description>What is Market Access Market access in the pharma industry refers to the process and strategies used to ensure that a drug or medical device is readily available to patients, is properly priced and reimbursed by healthcare systems. This can involve negotiations with regulators, healthcare providers, insurance companies, and policymakers. The goal of market access is to ensure that all patients who need a drug are able to receive it, regardless of their ability to pay.</description>
    </item>
    
  </channel>
</rss>
